References

  1. Summary of Product Characteristics (SPC): Arti-Cell Forte® Chondrogenic induced equine allogeneic peripheral blood derived mesenchymal stem cells. SPC available on the Veterinary Medicines Directorate website http://www.vmd.defra.gov.uk/ProductInformationDatabase.
  2. McIlwraith,C.W., Frisbie,D.D. and Kawcak,C.E. (2012) ‘The horse as a model of naturally occurring osteoarthritis’ Bone and Joint Research, 1(11), pp 297-309
  3. Broeckx SY, Seys B, Suls M, Vandenberghe A, Mariën T, Adriaensen E, Declercq J, Van Hecke L, Braun G, Hellmann K, Spaas JH.2019. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Stem Cells Dev. 28 (6) 410-422.
  4. Broeckx SY, Martens AM, Bertone AL, Van Brantegem L, Duchateau L, Van Hecke L, Dumoulin M, Oosterlinck M, Chiers K, Hussein H, Pille F, Spaas JH. 2019 The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: a randomized, doubleblinded, placebo-controlled proof-of-concept study. Equine Veterinary Journal (2019).
  5. Broeckx,S., Zimmerman,M., Crocetti,S., Suls,M., Marien,T., Ferguson,S.J., Chiers,K., Duchateau,L., Franco-Obregon,A., Wuertz,K. and Spaas,J.H.(2014)Regenerative therapies for equine degenerative joint disease: a preliminary study. PLoSONE 9,e85917.
  6. A Stifle OCD case study-Boehringer-Ingelheim-unpublished data.
  7. Metka Volga, NezaAdamic, Modest Vengust and Gregor Majdic.’Stem Cells in Veterinary Medicine- Current State and Treatment Options’. Front,Vet.Sci., 29th May 2020
  8. Spaas, J.H., Broeckx, S.Y., Chiers, K., Ferguson, S.J., Casarosa, M., Van Bruaene, N., Forsyth, R., Duchateau, L., Franco-Obregón, A., Wuertz-Kozak, K., 2015. Chondrogenic priming at reduced cell density enhances cartilage adhesion of equine allogeneic MSCs a loading sensitive phenomenon in an organ culture study with 180 explants. Cell. Physiol. Biochem. 37, 651–665.